Abstract
Papillary carcinoma of the thyroid is a common malignancy originating from the endocrine organs. The recent prevalence of ultrasonography (US) and US-guided fine needle aspiration biopsy (FNAB) can make us easily diagnose papillary carcinoma of 1.0 cm or less in maximal diameter, which is called papillary microcarcinoma. How to treat papillary microcarcinoma has been controversial. In autopsy studies, papillary carcinoma of 3-9.9 mm is frequently found as an occult carcinoma. Furthermore, papillary carcinoma of more than 3 mm was detected in 3.5% of otherwise healthy women aged 30 years or older by mass screening using US and FNAB, and 84% of them were less than 1.5 cm in diameter. These findings indicate that papillary microcarcinoma frequently remains occult. Thus, recently, a trial of observation without surgical treatment has been performed, which demonstrates that most papillary microcarcinoma do not grow or only slowly grow and observation can be a therapeutic strategy. On the other hand, previous reports demonstrated that papillary microcarcinoma frequently metastasizes to cervical lymph nodes and shows multiple tumor formation in the thyroid. Furthermore, cases with palpable nodal metastasis often show rapid progression and dire prognosis. In this review, we discuss the appropriate application of observation and surgical treatment of papillary microcarcinoma.
Keywords: thyroid cancer, microcarcinoma, surgery, observation
Current Cancer Therapy Reviews
Title: Therapeutic Strategies for Papillary Microcarcinoma of the Thyroid
Volume: 1 Issue: 1
Author(s): Yasuhiro Ito and Akira Miyauchi
Affiliation:
Keywords: thyroid cancer, microcarcinoma, surgery, observation
Abstract: Papillary carcinoma of the thyroid is a common malignancy originating from the endocrine organs. The recent prevalence of ultrasonography (US) and US-guided fine needle aspiration biopsy (FNAB) can make us easily diagnose papillary carcinoma of 1.0 cm or less in maximal diameter, which is called papillary microcarcinoma. How to treat papillary microcarcinoma has been controversial. In autopsy studies, papillary carcinoma of 3-9.9 mm is frequently found as an occult carcinoma. Furthermore, papillary carcinoma of more than 3 mm was detected in 3.5% of otherwise healthy women aged 30 years or older by mass screening using US and FNAB, and 84% of them were less than 1.5 cm in diameter. These findings indicate that papillary microcarcinoma frequently remains occult. Thus, recently, a trial of observation without surgical treatment has been performed, which demonstrates that most papillary microcarcinoma do not grow or only slowly grow and observation can be a therapeutic strategy. On the other hand, previous reports demonstrated that papillary microcarcinoma frequently metastasizes to cervical lymph nodes and shows multiple tumor formation in the thyroid. Furthermore, cases with palpable nodal metastasis often show rapid progression and dire prognosis. In this review, we discuss the appropriate application of observation and surgical treatment of papillary microcarcinoma.
Export Options
About this article
Cite this article as:
Ito Yasuhiro and Miyauchi Akira, Therapeutic Strategies for Papillary Microcarcinoma of the Thyroid, Current Cancer Therapy Reviews 2005; 1 (1) . https://dx.doi.org/10.2174/1573394052952546
DOI https://dx.doi.org/10.2174/1573394052952546 |
Print ISSN 1573-3947 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6301 |
Call for Papers in Thematic Issues
Current progress in Protein Degradation and Cancer Therapy
argeted Protein Degradation is gaining momentum in cancer therapy, it facilitate targeting undruggable proteins, it overcome cancer resistance and avoid undesirable side effects. Thus small molecules degraders have emerged as novel therapeutic strategy. Targeted protein degradation (TPD), the process of eliminating a protein of interest hold a great promise for ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Bioinformatics Approach for Data Capturing: The Case of Breast Cancer
Current Cancer Therapy Reviews A Novel Approach to Anticancer Therapies: Peroxisome Proliferator Activator-Receptor-γ as a New Target Therapy in the Treatment of Human Urological Cancer
Endocrine, Metabolic & Immune Disorders - Drug Targets Medications not Intended for Treatment of Dyslipidemias and with a Variable Effect on Lipids
Current Pharmaceutical Design 5-Benzylidene-3,4-dihalo-furan-2-one derivatives inhibit human leukemia cancer cells through suppression of NF-κB and GSK-3β
Anti-Cancer Agents in Medicinal Chemistry Targeting CSCs in Tumor Microenvironment: The Potential Role of ROS-Associated miRNAs in Tumor Aggressiveness
Current Stem Cell Research & Therapy Stem Cell Niche in Tissue Homeostasis, Aging and Cancer
Current Medicinal Chemistry Update on Hsp90 Inhibitors in Clinical Trial
Current Topics in Medicinal Chemistry Folic Acid Can Contribute to Memory Deficit and Na+, K+- ATPase Failure in the Hippocampus of Adolescent Rats Submitted to Hypoxia- Ischemia
CNS & Neurological Disorders - Drug Targets Merging Traditional Chinese Medicine with Modern Drug Discovery Technologies to Find Novel Drugs and Functional Foods
Current Drug Discovery Technologies Dietary Phytochemicals in Cancer Signalling Pathways: Role of miRNA Targeting
Current Medicinal Chemistry Calcium Channel Blockers in Obesity-Related Hypertension
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Analytical Methods for Metallothionein Detection
Current Analytical Chemistry Mutations in MicroRNA Genes and Their Binding Sites are Infrequently Associated with Human Colorectal Cancer in the Kashmiri Population
MicroRNA CD147 Interacts with NDUFS6 in Regulating Mitochondrial Complex I Activity and the Mitochondrial Apoptotic Pathway in Human Malignant Melanoma Cells
Current Molecular Medicine Bioengineering of Bacterial Magnetic Particles and their Applications in Biotechnology
Recent Patents on Biotechnology Selenium-Rich Foods: a Promising Approach to Colorectal Cancer Prevention
Current Pharmaceutical Biotechnology MET and ALK as Targets for the Treatment of NSCLC
Current Pharmaceutical Design Pharmacological Targeting of IDO-Mediated Tolerance for Treating Autoimmune Disease
Current Drug Metabolism Notch Signaling in Leukemias and Lymphomas
Current Molecular Medicine Adipobiology of Disease: Adipokines and Adipokine-Targeted Pharmacology
Current Pharmaceutical Design